Press Releases

04.26.2016

Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled

04.22.2016

CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published in The Lancet

04.21.2016

Pfizer Invites Public to Listen to Webcast of April 28 Annual Meeting of Shareholders

04.19.2016

AM-Pharma STOP-AKI Phase II trial nominated for “Most Innovative Clinical Trial Design” in 2016 CARE Awards

04.19.2016

Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)

04.07.2016

Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care

04.06.2016

Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®

04.06.2016

Pfizer Announces Termination of Proposed Combination with Allergan

04.05.2016

FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications

04.05.2016

Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinom

04.05.2016

Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis

04.04.2016

Pfizer and Allergan Issue Statement